|
HB 7 (BR 1187) - T. Burch, L. Belcher, W. Coursey, J. Greer, R. Meeks, C. Miller, J. Richards, G. Stumbo
AN ACT relating to drug importation.
Create new sections of KRS 217 to require the Governor, in coordination with the secretary of the Cabinet for Health Services, to request that the Secretary of the United States Department of Health and Human Services certify to Congress that drug importation from foreign countries by Kentucky licensed pharmacists, distributors, and wholesalers poses no additional risk to the public's health and safety and would result in a reduction in prescription drug costs; require the Governor and the secretary of the Cabinet for Health Services to request that the secretary of the Department for Health and Human Services promulgate administrative regulations permitting pharmacists, distributors, and wholesalers to import drugs from foreign countries; require the Cabinet for Health and Family Services to design a prescription drug program to facilitate the importation of prescription drugs from foreign countries by pharmacists, distributors, and wholesalers licensed in Kentucky once federal regulations have been promulgated; require that the program consist of a drug formulary and patient safety protections; specify requirements for the formulary; require that imported prescription drugs be available for sale to consumers and recipients of state health programs; require the cabinet to negotiate with pharmacists to ensure that any savings from imported drugs be passed on to consumers and state health programs; require pharmacies to sell imported drugs at the lesser of 120 percent of the amount paid for the imported drug or the amount that Medicaid reimburses for the drug; require an annual report to the Governor and the Legislative Research Commission regarding the effectiveness and cost savings of the program.
HB 7 - AMENDMENTS
HCS - Replace existing language with a requirement that the Governor and the secretary of the Cabinet for Health and Family Services coordinate a request to the federal Food and Drug Administration to report to the Governor, the cabinet secretary, and the LRC on whether drug importation from foreign pharmacies and distributors poses no additional risk to public health and would result in a significant reduction in the cost of prescription drugs; prohibit the cabinet secretary from designing a program to facilitate drug importation for resale in Kentucky unless the FDA certifies that drug importation poses no additional risk and would reduce the cost of prescription drugs.
Jan 9-introduced in House
Jan 11-to Health & Welfare (H)
Jan 17-posted in committee
Feb 7-reported favorably, 1st reading, to Calendar with Committee Substitute
Feb 8-2nd reading, to Rules; posted for passage in the Regular Orders of the Day for Monday, February 11, 2008
Feb 25-3rd reading, passed 95-0 with Committee Substitute
Feb 26-received in Senate
Feb 28-to Appropriations & Revenue (S)
Vote History
|
